Screener
Vera Therapeutics VERA Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Vera Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212143
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other assets, current | 19,042 | 14,294 |
| Total current assets | 615,802 | 728,883 |
| Other assets, noncurrent | 5,937 | 5,850 |
| Total assets | $621,739 | $734,733 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $13,909 | $21,898 |
| Accrued expenses and other liabilities, current | 31,240 | 31,557 |
Item 1. Financial Statements
FAQ
- What is Vera Therapeutics's total assets?
- Vera Therapeutics (VERA) reported total assets of $621.74M in Q1 2026.
- How has Vera Therapeutics's total assets changed year-over-year?
- Vera Therapeutics's total assets increased by 1.9% year-over-year, from $610.17M to $621.74M.
- What is the long-term trend for Vera Therapeutics's total assets?
- Over 5 years (2020 to 2025), Vera Therapeutics's total assets has grown at a 68.2% compound annual growth rate (CAGR), from $54.55M to $734.73M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Vera Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude